Healthcare provider profile · identity verified

Richard A Irvin

Family Practice · WHEELING, WV · NPI 1083603336

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	364	94
Atorvastatin Calcium	Atorvastatin Calcium	307	78
Omeprazole	Omeprazole	280	72
Levothyroxine Sodium	Levothyroxine Sodium	262	58
Simvastatin	Simvastatin	229	64
Gabapentin	Gabapentin	227	35
Rosuvastatin Calcium	Rosuvastatin Calcium	216	64
Amlodipine Besylate	Amlodipine Besylate	209	61
Hydrochlorothiazide	Hydrochlorothiazide	171	45
Metformin Hcl	Metformin Hcl	168	44
Sertraline Hcl	Sertraline Hcl	142	35
Losartan Potassium	Losartan Potassium	138	34
Albuterol Sulfate Hfa	Albuterol Sulfate	131	25
Pantoprazole Sodium	Pantoprazole Sodium	113	32
Metformin Hcl Er	Metformin Hcl	107	27
Tamsulosin Hcl	Tamsulosin Hcl	107	29
Famotidine	Famotidine	100	26
Metoprolol Tartrate	Metoprolol Tartrate	98	25
Olmesartan Medoxomil	Olmesartan Medoxomil	98	26
Metoprolol Succinate	Metoprolol Succinate	95	26
Duloxetine Hcl	Duloxetine Hcl	94	23
Alendronate Sodium	Alendronate Sodium	87	30
Furosemide	Furosemide	87	25
Meloxicam	Meloxicam	86	24
Ozempic	Semaglutide	86	12
Pravastatin Sodium	Pravastatin Sodium	80	19
Fluticasone Propionate	Fluticasone Propionate	64	32
Potassium Chloride	Potassium Chloride	64	21
Venlafaxine Hcl Er	Venlafaxine Hcl	64	18
Tramadol Hcl	Tramadol Hcl	62	12
Alprazolam	Alprazolam	59	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	16
Warfarin Sodium	Warfarin Sodium	58	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	13
Atenolol	Atenolol	52	14
Carvedilol	Carvedilol	52	suppressed
Montelukast Sodium	Montelukast Sodium	52	16
Allopurinol	Allopurinol	51	15
Celecoxib	Celecoxib	51	19
Eliquis	Apixaban	51	14
Ezetimibe	Ezetimibe	48	11
Escitalopram Oxalate	Escitalopram Oxalate	47	11
Buspirone Hcl	Buspirone Hcl	46	12
Valsartan	Valsartan	45	11
Ibuprofen	Ibuprofen	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	11
Trulicity	Dulaglutide	40	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Synthroid	Levothyroxine Sodium	38	11
Donepezil Hcl	Donepezil Hcl	36	suppressed
Spiriva Handihaler	Tiotropium Bromide	36	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Lovastatin	Lovastatin	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Finasteride	Finasteride	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Dutasteride	Dutasteride	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Phenobarbital	Phenobarbital	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Prednisone	Prednisone	18	11
Pregabalin	Pregabalin	18	suppressed
Silodosin	Silodosin	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Tiotropium Bromide	Tiotropium Bromide	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Xarelto	Rivaroxaban	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ramipril	Ramipril	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error